feed,title,long_url,short_url
Benzinga,Dollar Tree Q1 Earnings: Taking a Look at Key Metrics Versus Estimates,https://benzinga.com/news/earnings/24/06/39186689/dollar-tree-q1-earnings-taking-a-look-at-key-metrics-versus-estimates,https://da.gd/fr3eu
Benzinga,Thor Industries Reports Q3 Earnings: What Key Metrics Have to Say,https://benzinga.com/news/earnings/24/06/39186691/thor-industries-reports-q3-earnings-what-key-metrics-have-to-say,https://da.gd/8GuUfV
Benzinga,REV Group Q2 Earnings: Taking a Look at Key Metrics Versus Estimates,https://benzinga.com/news/earnings/24/06/39186692/rev-group-q2-earnings-taking-a-look-at-key-metrics-versus-estimates,https://da.gd/eEp0Cf
Benzinga,Bath & Body Works To See More Comfort In Second Half Numbers With Further Improvement: Analysts,https://benzinga.com/analyst-ratings/analyst-color/24/06/39192643/bath-body-works-to-see-more-comfort-in-second-half-numbers-with-further-improvement,https://da.gd/8uDr
Benzinga,Amgen Seeks Expanded US Approval For Autoimmune Disease Drug Acquired Via $28B Horizon Deal,https://benzinga.com/general/biotech/24/06/39192642/amgen-seeks-expanded-us-approval-for-autoimmune-disease-drug-acquired-via-28b-horizon-deal,https://da.gd/CSuHL
Benzinga,BNY Mellon Boosts Investment Solutions via Bundle Services,https://benzinga.com/news/24/06/39188651/bny-mellon-boosts-investment-solutions-via-bundle-services,https://da.gd/tWOl6
